Corynebacterium diphtheriae CRM197 protein Completed Phase 3 Trials for Measles / Measles-Mumps-Rubella Vaccine / Rubella / Mumps Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01681992Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life